M&T Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $588K | Hold |
4,601
| – | – | ﹤0.01% | 1038 |
|
|
2025
Q4 | $561K | Sell |
4,601
-904
| -16% | -$104K | ﹤0.01% | 1063 |
|
|
2025
Q3 | $552K | Hold |
5,505
| – | – | ﹤0.01% | 950 |
|
|
2025
Q2 | $457K | Hold |
5,505
| – | – | ﹤0.01% | 1112 |
|
|
2025
Q1 | $446K | Sell |
5,505
-4,062
| -42% | -$363K | ﹤0.01% | 1111 |
|
|
2024
Q4 | $862K | Buy |
9,567
+4,366
| +84% | +$423K | ﹤0.01% | 950 |
|
|
2024
Q3 | $514K | Hold |
5,201
| – | – | ﹤0.01% | 1154 |
|
|
2024
Q2 | $482K | Sell |
5,201
-40
| -0.8% | -$3.59K | ﹤0.01% | 1128 |
|
|
2024
Q1 | $497K | Sell |
5,241
-2,466
| -32% | -$229K | ﹤0.01% | 1148 |
|
|
2023
Q4 | $688K | Buy |
7,707
+2,301
| +43% | +$171K | ﹤0.01% | 1004 |
|
|
2023
Q3 | $395K | Sell |
5,406
-1,155
| -18% | -$92.3K | ﹤0.01% | 1179 |
|
|
2023
Q2 | $546K | Hold |
6,561
| – | – | ﹤0.01% | 1086 |
|
|
2023
Q1 | $500K | Sell |
6,561
-7,364
| -53% | -$611K | ﹤0.01% | 1115 |
|
|
2022
Q4 | $1.16M | Buy |
13,925
+348
| +3% | +$28.2K | ﹤0.01% | 804 |
|
|
2022
Q3 | $1.08M | Sell |
13,577
-100
| -0.7% | -$8.43K | ﹤0.01% | 798 |
|
|
2022
Q2 | $1.01M | Sell |
13,677
-876
| -6% | -$65.8K | ﹤0.01% | 771 |
|
|
2022
Q1 | $1.31M | Buy |
14,553
+12,271
| +538% | +$1.13M | 0.01% | 679 |
|
|
2021
Q4 | $255K | Hold |
2,282
| – | – | ﹤0.01% | 1331 |
|
|
2021
Q3 | $287K | Sell |
2,282
-785
| -26% | -$101K | ﹤0.01% | 1256 |
|
|
2021
Q2 | $415K | Buy |
+3,067
| New | +$403K | ﹤0.01% | 1111 |
|
|
2021
Q1 | – | Sell |
-1,676
| Closed | -$236K | – | 1738 |
|
|
2020
Q4 | $236K | Sell |
1,676
-442
| -21% | -$56.6K | ﹤0.01% | 1442 |
|
|
2020
Q3 | $236K | Sell |
2,118
-1,347
| -39% | -$151K | ﹤0.01% | 1348 |
|
|
2020
Q2 | $388K | Buy |
+3,465
| New | +$341K | ﹤0.01% | 1068 |
|
|
2019
Q4 | – | Sell |
-15,169
| Closed | -$1.16M | – | 1663 |
|
|
2019
Q3 | $1.16M | Sell |
15,169
-96
| -0.6% | -$7.98K | 0.01% | 678 |
|
|
2019
Q2 | $1.34M | Sell |
15,265
-1,097
| -7% | -$93.6K | 0.01% | 644 |
|
|
2019
Q1 | $1.48M | Sell |
16,362
-93
| -0.6% | -$7.91K | 0.01% | 606 |
|
|
2018
Q4 | $1.18M | Sell |
16,455
-660
| -4% | -$53.2K | 0.01% | 632 |
|
|
2018
Q3 | $1.64M | Buy |
17,115
+82
| +0.5% | +$7.95K | 0.01% | 600 |
|
|
2018
Q2 | $1.62M | Sell |
17,033
-122
| -0.7% | -$11.2K | 0.01% | 601 |
|
|
2018
Q1 | $1.5M | Buy |
17,155
+1,915
| +13% | +$175K | 0.01% | 629 |
|
|
2017
Q4 | $1.29M | Buy |
15,240
+224
| +1% | +$18.8K | 0.01% | 677 |
|
|
2017
Q3 | $1.3M | Buy |
15,016
+210
| +1% | +$16.8K | 0.01% | 668 |
|
|
2017
Q2 | $1.14M | Sell |
14,806
-157
| -1% | -$11.1K | 0.01% | 700 |
|
|
2017
Q1 | $1.04M | Sell |
14,963
-2,135
| -12% | -$143K | 0.01% | 741 |
|
|
2016
Q4 | $1.01M | Buy |
17,098
+2,256
| +15% | +$139K | 0.01% | 758 |
|
|
2016
Q3 | $984K | Buy |
14,842
+1,720
| +13% | +$106K | 0.01% | 782 |
|
|
2016
Q2 | $710K | Buy |
13,122
+109
| +0.8% | +$5.97K | ﹤0.01% | 892 |
|
|
2016
Q1 | $672K | Sell |
13,013
-615
| -5% | -$31.9K | ﹤0.01% | 933 |
|
|
2015
Q4 | $956K | Sell |
13,628
-159
| -1% | -$10.8K | 0.01% | 808 |
|
|
2015
Q3 | $858K | Sell |
13,787
-541
| -4% | -$42.6K | 0.01% | 870 |
|
|
2015
Q2 | $1.21M | Sell |
14,328
-3,168
| -18% | -$246K | 0.01% | 805 |
|
|
2015
Q1 | $1.31M | Sell |
17,496
-585
| -3% | -$40.9K | 0.01% | 763 |
|
|
2014
Q4 | $1.12M | Buy |
18,081
+450
| +3% | +$25.7K | 0.01% | 804 |
|
|
2014
Q3 | $917K | Buy |
17,631
+2,631
| +18% | +$134K | 0.01% | 932 |
|
|
2014
Q2 | $770K | Hold |
15,000
| – | – | 0.03% | 344 |
|
|
2014
Q1 | $712K | Hold |
15,000
| – | – | 0.03% | 341 |
|
|
2013
Q4 | $651K | Hold |
15,000
| – | – | 0.03% | 346 |
|
|
2013
Q3 | $646K | Hold |
15,000
| – | – | 0.03% | 299 |
|
|
2013
Q2 | $521K | Buy |
+15,000
| New | +$527K | 0.03% | 315 |
|
Other funds holding XBI
M&T Bank's XBI Position: Q1 2026 in Review
M&T Bank held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 4,601 shares worth $588K. The position accounts for ﹤0.01% of the portfolio, ranked #1038.
M&T Bank first reported a position in XBI in Q2 2013 and has held it in 49 quarters since. The position peaked at $1.64M in Q3 2018. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- M&T Bank held 4,601 shares of State Street SPDR S&P Biotech ETF worth $588K as of Q1 2026.
- M&T Bank left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #1038 holding.
- M&T Bank first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 49 quarters since.
- M&T Bank's State Street SPDR S&P Biotech ETF position peaked at $1.64M in Q3 2018.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.